C50.11
Malignant neoplasm of central portion of breast, female
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the central portion of the breast, specifically in females, refers to breast cancer that originates in the central area of the breast tissue. This type of cancer is one of the many forms of breast cancer categorized under ICD-10 code C50.11. It usually involves the area around the nipple and areola, affecting a significant portion of the breast's middle region. Early detection and treatment are essential for improving outcomes, making awareness of this diagnosis crucial for women.
Causes & Symptoms
Clinical Causes: Genetic mutations or inherited gene mutations (e.g., BRCA1, BRCA2) Hormonal factors, such as prolonged exposure to estrogen Age, with increased risk as women get older Family history of breast cancer Previous personal history of breast cancer or benign breast disease Radiation exposure to the chest area Lifestyle factors, including excessive alcohol consumption and obesity Reproductive history, such as early menarche or late menopause
Key Symptoms: A lump or thickening in the central part of the breast, near the nipple Changes in the size, shape, or appearance of the breast Nipple abnormalities, such as inversion, discharge, or skin changes Persistent pain or tenderness in the central breast area Skin redness or puckering over the breast surface Ulceration or bleeding from the nipple or skin Swelling of the breast or nearby lymph nodes
Diagnostic & Treatment
Diagnosis Path: Mammography: To visualize abnormal growths or lumps in the central breast area Ultrasound: To evaluate the nature of the lump and its surroundings Biopsy: Removing a small tissue sample for laboratory analysis to confirm malignancy Magnetic Resonance Imaging (MRI): For detailed imaging, especially in dense breast tissue Other tests, such as CT scans or PET scans, may be utilized to determine the extent of the disease
Treatment Protocols: Surgical removal of the tumor, such as mastectomy (removal of the entire breast) or lumpectomy (removal of the tumor alone) Radiation therapy to eliminate remaining cancerous cells after surgery Chemotherapy to target cancer cells throughout the body Hormone therapy, if the tumor is hormone receptor-positive Targeted therapy drugs designed to interfere with specific molecules involved in tumor growth Immunotherapy to boost the body's immune response against cancer cells
Clinical Advice & FAQs
Billing Guidance
Is C50.11 a billable ICD-10 code?
Yes, C50.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.11?
Clinical documentation must specify the nature of Malignant neoplasm of central portion of breast, female and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
